首页> 美国卫生研究院文献>other >Structurally constrained hybrid derivatives containing octahydrobenzog or fquinoline moieties for dopamine D2 and D3 receptors: Binding characterization at D2/D3 receptors and elucidation of a pharmacophore model
【2h】

Structurally constrained hybrid derivatives containing octahydrobenzog or fquinoline moieties for dopamine D2 and D3 receptors: Binding characterization at D2/D3 receptors and elucidation of a pharmacophore model

机译:多巴胺D2和D3受体的含有八氢苯并g或f喹啉部分的结构受限杂化衍生物:D2 / D3受体的结合特征和药效团模型的阐明

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of structurally constrained analogues based on hybrid compounds containing octahydrobenzo[g or f]quinoline moieties were designed, synthesized and characterized for their binding to dopamine D2 and D3 receptors expressed in HEK-293 cells. Among the newly developed constrained molecules, trans-octahydrobenzo[f]-quinolin-7-ol (>8) exhibited the highest affinity for D2 and D3 receptors; the (−)-isomer being the eutomer. Interestingly, this hybrid constrained version >8 showed significant affinity over the corresponding non-hybrid version >1 (representing a constrained version of the aminotetralin structure only) when assayed under same conditions (Ki 49.1 and 14.9 nM for >8 vs. 380 and 96.0 nM for >1 at D2 and D3, respectively). Similar results were found with other lead hybrid compounds, indicating a contribution of the piperazine moiety in the observed enhanced affinity. Based on the data of new lead constrained derivatives and other lead hybrid derivatives developed by us, a unique pharmacophore model was proposed consisting of three pharmacophoric centers, two with aromatic/hydrophobic and one with cationic features.
机译:设计,合成了一系列基于包含八氢苯并[g或f]喹啉基团的杂合化合物的结构受限的类似物,并对其结合在HEK-293细胞中表达的多巴胺D2和D3受体进行了表征。在新开发的受限分子中,反式八氢苯并[f]-喹啉-7-ol(> 8 )对D2和D3受体的亲和力最高。 (-)-异构体是eutomer。有趣的是,在相同条件下(Ki)进行分析时,此杂化约束版本> 8 与相应的非杂化版本> 1 (仅表示氨基四氢萘结构的受约束版本)相比具有显着的亲和力。在D2和D3,> 8 分别为49.1和14.9 nM,而> 1 分别为380和96.0 nM。在其他先导杂化化合物中发现了相似的结果,表明哌嗪部分在观察到的亲和力增强中的贡献。根据我们开发的新的铅约束衍生物和其他铅杂合物衍生物的数据,提出了一种独特的药效团模型,该模型由三个药效团中心组成,两个具有芳香/疏水性,一个具有阳离子特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号